New inhaled therapy aims to save ventilator patients from viral pneumonia
Disease control
Recruiting now
This study tests an inhaled medicine called SNG001 in patients with severe viral pneumonia who need a breathing machine. The goal is to see if it safely helps clear the virus faster and lowers the risk of death. About 550 adults, mostly over 50 or with weakened immune systems, wi…
Phase: PHASE2 • Sponsor: Synairgen Research Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC